Turning aging cells into a live vaccine: engineered senescent cancer cells with adjuvant celecoxib for immunotherapy
Yuewei Wang, Ante Ou, Yanli Luo, Yanrong Gao, Yi Zhang, Linxi Qin, Yongzhuo Huang
This study develops a live vaccine using engineered senescent tumor cells and celecoxib to enhance immunotherapy against melanoma and pancreatic tumors.
bioRxiv · Oct 6, 2026 · PreprintBioengineering